Ancestral Mutations Drive 50 Percent of Lynch Syndrome Cases, Suggests Review

While genetic heterogeneity and variable penetrance often hinder the identification of early-onset colorectal cancer (CRC) genes, studying isolated founder populations can overcome these clinical barriers. To address this, Nirmal Raj Rajaram from the University of Oxford and Paramjot Kaur from the All India Institute of Medical Sciences (AIIMS), Raipur, reviewed how Finland’s unique demographic history enabled the mapping of recurrent germline MutL Homolog 1 (MLH1) mutations in the deoxyribonucleic acid (DNA) mismatch repair (MMR) pathway.

Therefore, the descriptive review uses Finnish biobank data and historical registries from 1634 to map DNA repair mutations using pedigree linkage and a LOD score threshold over three. Due to its population-wide design, the study identifies disease-causing loci without specifying clinical exclusion criteria or trial endpoints.

Key Clinical Findings of the Review Includes:

• High Mutational Prevalence: Study shows that a 3.5-kilobase genomic deletion in exon 16 and a splice acceptor mutation in exon 6 account for 63% of Finnish hereditary non-polyposis colorectal cancer families.

• Lynch Syndrome Burden: Analysis confirms that the exon 16 deletion alone is responsible for approximately 50% of Lynch syndrome cases nationwide.

• Ancestral Mutation Origin: Investigation proves these mutations arose from historical founder events with shared haplotypes rather than recurring mutational hotspots.

• Enhanced Analytical Precision: Research demonstrates that reduced allelic diversity enables exceptionally precise penetrance estimates and robust genotype-phenotype correlations compared to outbred cohorts.

• Extra-Colonic Cancer Susceptibility: Review associates these germline mismatch repair variants with increased risks for extra-colonic malignancies, most frequently identifying endometrial cancer as the most common extra-colonic manifestation.

The results suggest that leveraging founder population genetics, where a threshold LOD score greater than three proves linkage, significantly enhances the efficiency of mapping high-penetrance cancer susceptibility genes. This demographic approach successfully identified major ancestral mutations accounting for up to 63% of hereditary colorectal cancer families, illustrating how historical isolation shapes contemporary oncological risk.

Thus, the review concludes clinicians can leverage these localized mutational profiles to optimize universal microsatellite instability (MSI) screening and establish targeted surveillance plans alongside family-wide cascade testing for high-risk individuals.

Although these findings are constrained by limited generalizability to genetically diverse populations and potential ascertainment bias in family-based cohorts, future clinical efforts should focus on integrating founder population data with broad genome-wide association studies (GWAS) and tumor sequencing to refine risk stratification globally.

Reference

Rajaram, N. R., & Kaur, P. (2026). The Finnish founder population and MLH1 mutations in hereditary colorectal cancer. Indian Journal of Cancer, Ahead of Print. Digital Object Identifier.